PANGIAM ULTIMATE HOLDINGS, LLC
Known title: DirectorCIK: 0001832284
Associated companies
Transaction History
| BBAI | ▲ Buy | Grant | 36,070 | $0 | 6/14/2026 | View on chart |
| BBAI | ▲ Buy | Grant | 65,822 | $0 | 6/2/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 27,430,402 | $78.5M | 4/8/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 5,150 | $18K | 3/26/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 2,314,872 | $8.2M | 3/17/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 5,216,361 | $18.2M | 3/14/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 1,707,837 | $5.6M | 3/13/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 3,629,108 | $12.1M | 3/12/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 3,137,293 | $10.5M | 3/10/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 2,660,841 | $8.9M | 3/7/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 4,149,559 | $17.9M | 3/6/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 4,089,824 | $18.9M | 3/5/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 4,624,979 | $21.5M | 3/4/2025 | View on chart |
| BBAI | ▼ Sell | Open Market | 5,015,919 | $25.7M | 3/3/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BBAI Gains 11.7% on $225M+ Federal Contract Awards
BBAI announced it received more than $225 million in new federal contracts covering homeland security, defense, intelligence and civilian agencies. The announcement lifted the stock 11.7% on Oct. 13. The contracts add to the company’s growing defense‑technology portfolio. The shares remain below the 52‑week low and are trading near a $4.09 support level.
BBAI Gains 11.7% on $225M+ Federal Contract Awards. BBAI announced it received more than $225 million in new federal contracts covering homeland security, defense, intelligence and civilian agencies. The announcement lifted the stock 11.7% on Oct. 13. The contracts add to the company’s growing defense‑technology portfolio. The shares remain below the 52‑week low and are trading near a $4.09 support level.